China SXT Pharmaceuticals Inc Cash Flow Quality Index
China SXT Pharmaceuticals Inc cash flow quality index. China SXT Pharmaceuticals Inc (SXTC) has a Cash Flow Quality Index of -13.83x as of June 2026. Operating cash flow of $-2.26 Million is below net income of $163.72K, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is China SXT Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of China SXT Pharmaceuticals Inc (2016–2019)
Cash flow quality index of China SXT Pharmaceuticals Inc from 2016 to 2019. Historical Cash Flow Quality Index for China SXT Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore China SXT Pharmaceuticals Inc (SXTC) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
China SXT Pharmaceuticals Inc Cash Flow Quality Index by Year (2016–2019)
China SXT Pharmaceuticals Inc cash flow quality index by year from 2016 to 2019. Year-by-year earnings quality comparison for China SXT Pharmaceuticals Inc. For the full cash flow conversion analysis, see SXTC operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 0.16x | $239.19K | $1.54 Million | ▼ -90.4% |
| 2018 | 1.62x | $1.92 Million | $1.19 Million | ▲ +553.9% |
| 2017 | 0.25x | $293.04K | $1.19 Million | ▼ -80.8% |
| 2016 | 1.29x | $182.47K | $141.54K | — |